MYC Deregulation in Gastric Cancer and Its Clinicopathological Implications

Our study investigated the relationship between MYC alterations and clinicopathological features in gastric cancers. We evaluated the effect of MYC mRNA expression and its protein immunoreactivity, as well as copy number variation, promoter DNA methylation, and point mutations, in 125 gastric adenocarcinoma and 67 paried non-neoplastic tissues. We observed that 77% of the tumors presented MYC immunoreactivity which was significantly associated with increased mRNA expression (p<0.05). These observations were associated with deeper tumor extension and the presence of metastasis (p<0.05). MYC protein expression was also more frequently observed in intestinal-type than in diffuse-type tumors (p<0.001). Additionally, MYC mRNA and protein expression were significantly associated with its copy number (p<0.05). The gain of MYC copies was associated with late-onset, intestinal-type, advanced tumor stage, and the presence of distant metastasis (p<0.05). A hypomethylated MYC promoter was detected in 86.4% of tumor samples. MYC hypomethylation was associated with diffuse-type, advanced tumor stage, deeper tumor extension, and the presence of lymph node metastasis (p<0.05). Moreover, eighteen tumor samples presented at least one known mutation. The presence of MYC mutations was associated with diffuse-type tumor (p<0.001). Our results showed that MYC deregulation was mainly associated with poor prognostic features and also reinforced the presence of different pathways involved in intestinal-type and diffuse-type gastric carcinogenesis. Thus, our findings suggest that MYC may be a useful marker for clinical stratification and prognosis.

[1]  Hong-Gang Liu,et al.  Detection of C‐MYC oncogene translocation and copy number change in the normal‐dysplasia‐carcinoma sequence of the larynx by fluorescence in situ hybridization , 2013, Diagnostic cytopathology.

[2]  N. Caplen,et al.  The 8q24 Gene Desert: An Oasis of Non-Coding Transcriptional Activity , 2012, Front. Gene..

[3]  Xin Chen,et al.  Integration of DNA Copy Number Alterations and Transcriptional Expression Analysis in Human Gastric Cancer , 2012, PloS one.

[4]  Chi V Dang,et al.  MYC on the Path to Cancer , 2012, Cell.

[5]  Z. Long,et al.  The Prognostic Significance of Apoptosis-Related Biological Markers in Chinese Gastric Cancer Patients , 2011, PloS one.

[6]  S. Sinha,et al.  CpG hypermethylation of the C-myc promoter by dsRNA results in growth suppression. , 2011, Molecular pharmaceutics.

[7]  Wen-Ching Chan,et al.  Aberrant hypermethylation of miR-9 genes in gastric cancer , 2011, Epigenetics.

[8]  P. Assumpção,et al.  Experimental Gastric Carcinogenesis in Cebus apella Nonhuman Primates , 2011, PloS one.

[9]  A. Khayat,et al.  MYC, TP53, and Chromosome 17 Copy-Number Alterations in Multiple Gastric Cancer Cell Lines and in Their Parental Primary Tumors , 2011, Journal of biomedicine & biotechnology.

[10]  Xue Zhang,et al.  Analysis of DNA copy number aberrations by multiple ligation‐dependent probe amplification on 50 intestinal type gastric cancers , 2011, Journal of surgical oncology.

[11]  M. Esteller,et al.  Epigenetic modifications and human disease , 2010, Nature Biotechnology.

[12]  P. Assumpção,et al.  MYC in gastric carcinoma and intestinal metaplasia of young adults. , 2010, Cancer genetics and cytogenetics.

[13]  R. Burbano,et al.  Cytogenetic characterization and evaluation of c-MYC gene amplification in PG100, a new Brazilian gastric cancer cell line. , 2010, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[14]  M. Guo,et al.  Inhibitory effect of S-adenosylmethionine on the growth of human gastric cancer cells in vivo and in vitro. , 2010, Chinese journal of cancer.

[15]  A. Jemal,et al.  Global Patterns of Cancer Incidence and Mortality Rates and Trends , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[16]  M. Harada,et al.  Promoter polymorphisms and methylation of E-cadherin (CDH1) and KIT in gastric cancer patients from northern Brazil. , 2010, Anticancer research.

[17]  J. Ajani,et al.  Gastric cancer--an enigmatic and heterogeneous disease. , 2010, JAMA.

[18]  Derek Y. Chiang,et al.  The landscape of somatic copy-number alteration across human cancers , 2010, Nature.

[19]  I. Cabral,et al.  Establishment and conventional cytogenetic characterization of three gastric cancer cell lines. , 2009, Cancer genetics and cytogenetics.

[20]  S. Goodman,et al.  Sensitive digital quantification of DNA methylation in clinical samples , 2009, Nature Biotechnology.

[21]  H. Grabsch,et al.  High resolution analysis of DNA copy-number aberrations of chromosomes 8, 13, and 20 in gastric cancers , 2009, Virchows Archiv.

[22]  W. Ling,et al.  Assessment of the effect of betaine on p16 and c-myc DNA methylation and mRNA expression in a chemical induced rat liver cancer model , 2009, BMC Cancer.

[23]  A. Khayat,et al.  MYC insertions in diffuse-type gastric adenocarcinoma. , 2009, Anticancer research.

[24]  L. Penn,et al.  Reflecting on 25 years with MYC , 2008, Nature Reviews Cancer.

[25]  P. Assumpção,et al.  MYC and gastric adenocarcinoma carcinogenesis. , 2008, World journal of gastroenterology.

[26]  A. Khayat,et al.  Interrelationship between MYC gene numerical aberrations and protein expression in individuals from northern Brazil with early gastric adenocarcinoma. , 2008, Cancer genetics and cytogenetics.

[27]  Jing-Yuan Fang,et al.  Folate levels in mucosal tissue but not methylenetetrahydrofolate reductase polymorphisms are associated with gastric carcinogenesis. , 2006, World journal of gastroenterology.

[28]  A. Khayat,et al.  Interrelationship between chromosome 8 aneuploidy, C-MYC amplification and increased expression in individuals from northern Brazil with gastric adenocarcinoma. , 2006, World journal of gastroenterology.

[29]  A. Khayat,et al.  Aneuploidy of chromosome 8 detected by fluorescence in situ hybridisation in ACP01 cell line gastric adenocarcinoma , 2006, Clinical and Experimental Medicine.

[30]  A. Khayat,et al.  Numerical aberrations of chromosome 8 detected by conventional cytogenetics and fluorescence in situ hybridization in individuals from northern Brazil with gastric adenocarcinoma. , 2006, Cancer genetics and cytogenetics.

[31]  A. Khayat,et al.  C-MYC locus amplification as metastasis predictor in intestinal-type gastric adenocarcinomas: CGH study in Brazil. , 2006, Anticancer research.

[32]  E. El-Omar,et al.  Cellular and molecular aspects of gastric cancer. , 2006, World journal of gastroenterology.

[33]  H. Fujii,et al.  CpG Island M`ethylation Status in Gastric Carcinoma with and without Infection of Epstein-Barr Virus , 2006, Clinical Cancer Research.

[34]  Kentaro Yamashita,et al.  Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. , 2006, Cancer cell.

[35]  P. Assumpção,et al.  Aneuploidy of chromosome 8 and C-MYC amplification in individuals from northern Brazil with gastric adenocarcinoma. , 2005, Anticancer research.

[36]  M. Paz,et al.  Differential DNA hypermethylation and hypomethylation signatures in colorectal cancer. , 2005, Human molecular genetics.

[37]  Li Yang,et al.  Expression of Dnmt1, demethylase, MeCP2 and methylation of tumor-related genes in human gastric cancer. , 2004, World journal of gastroenterology.

[38]  Papaggeli Pc,et al.  Aberrant methylation of c-myc and c-fos protooncogenes and p53 tumor suppressor gene in myelodysplastic syndromes and acute non-lymphocytic leukemia. , 2003, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[39]  S. Pelengaris,et al.  The many faces of c-MYC. , 2003, Archives of biochemistry and biophysics.

[40]  G. Nardone,et al.  Review article: molecular basis of gastric carcinogenesis. , 2003, Alimentary pharmacology & therapeutics.

[41]  Andrea Cocito,et al.  Genomic targets of the human c-Myc protein. , 2003, Genes & development.

[42]  M. Ehrlich,et al.  DNA methylation in cancer: too much, but also too little , 2002, Oncogene.

[43]  G. Evan,et al.  Suppression of Myc-Induced Apoptosis in β Cells Exposes Multiple Oncogenic Properties of Myc and Triggers Carcinogenic Progression , 2002, Cell.

[44]  S. Raptis,et al.  Application of multiplex fluorescence in situ hybridization in the cytogenetic analysis of primary gastric carcinoma. , 2002, Cancer genetics and cytogenetics.

[45]  M. Eilers,et al.  Contributions of Myc to tumorigenesis. , 2002, Biochimica et biophysica acta.

[46]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[47]  G. Evan,et al.  Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. , 1999, Molecular cell.

[48]  P. Laird,et al.  COBRA: a sensitive and quantitative DNA methylation assay. , 1997, Nucleic acids research.

[49]  L. Shen,et al.  [Correlation between hypomethylation of c-myc and c-N-ras oncogenes and pathological changes in human hepatocellular carcinoma]. , 1997, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[50]  S. Xiao,et al.  Relationship of plasma folic acid and status of DNA methylation in human gastric cancer , 1997, Journal of Gastroenterology.

[51]  S. Xiao,et al.  Studies on the hypomethylation of c‐myc, c‐Ha‐ras oncogenes and histopathological changes in human gastric carcinoma , 1996, Journal of gastroenterology and hepatology.

[52]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[53]  K. Ryan,et al.  Myc oncogenes: the enigmatic family. , 1996, The Biochemical journal.

[54]  D. Shibata,et al.  Epstein-Barr virus-associated gastric adenocarcinoma among Japanese Americans in Hawaii. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[55]  P. Correa,et al.  Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. , 1992, Cancer research.

[56]  A. Shorthouse,et al.  Patterns of methylation of the c-myc gene in human colorectal cancer progression. , 1992, British Journal of Cancer.

[57]  J W Gray,et al.  Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[58]  R. Gallo,et al.  onc gene amplification in promyelocytic leukaemia cell line HL-60 and primary leukaemic cells of the same patient , 1982, Nature.

[59]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[60]  P. Laurén,et al.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. , 1965, Acta pathologica et microbiologica Scandinavica.

[61]  A. Loriot,et al.  DNA hypomethylation and activation of germline-specific genes in cancer. , 2013, Advances in experimental medicine and biology.

[62]  Wei Liu,et al.  Case-control study of single nucleotide polymorphisms of PSCA and MUC1 genes with gastric cancer in a Chinese. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[63]  Sampsa Hautaniemi,et al.  Characterization of the colorectal cancer-associated enhancer MYC-335 at 8q24: the role of rs67491583. , 2012, Cancer genetics.

[64]  S. Amente,et al.  Epigenetic reprogramming of Myc target genes. , 2011, American journal of cancer research.

[65]  D. Park,et al.  MYC quantitation in cell-free plasma DNA by real-time PCR for gastric cancer diagnosis , 2009, Clinical chemistry and laboratory medicine.

[66]  Leslie H. Sobin,et al.  TNM Classification of Malignant Tumours, 7th Edition , 2009 .

[67]  P. Devilee,et al.  In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors , 2004, Histochemistry.

[68]  E. Tahara.  Genetic pathways of two types of gastric cancer. , 2004, IARC scientific publications.